XBiotech (XBIT) SEC Filings & 10K Form $3.06 -0.09 (-2.73%) As of 02:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent XBiotech SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/19/20252:03 PMSIMARD JOHN (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/18/20252:36 PMXBiotech (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/04/20253:53 PMSIMARD JOHN (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/27/20251:36 PMSIMARD JOHN (Filed by)XBiotech (Subject)Form SCHEDULE 13G/A01/27/20251:39 PMMCKENZIE W THORPE (Filed by)XBiotech (Subject)Form SCHEDULE 13G/A12/31/20242:22 PMXBiotech (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/13/20242:12 PMXBiotech (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/12/20241:38 PMXBiotech (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 06/21/20241:15 PMLibby Peter (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 06/21/20241:15 PMMacAdam Donald H. (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 06/21/20241:16 PMWaldin Jan-Paul (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 06/21/20241:16 PMMCKENZIE W THORPE (Reporting)XBiotech (Issuer)Form 4Statement of changes in beneficial ownership of securities 06/20/202411:57 AMXBiotech (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/10/202410:27 AMXBiotech (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/01/20243:46 PMXBiotech (Filer)Form DEFA14A05/01/20243:49 PMXBiotech (Filer)Form ARS05/01/20243:44 PMXBiotech (Filer)Form DEF 14A05/01/20242:32 PMXBiotech (Filer)Form 10-K/A(Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies Zevra Therapeutics 10K Form Revance Therapeutics 10K Form SIGA Technologies 10K Form Ginkgo Bioworks 10K Form SNDL 10K Form Autolus Therapeutics 10K Form Relay Therapeutics 10K Form Rapport Therapeutics 10K Form Erasca 10K Form Sana Biotechnology 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:XBIT) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | Sponsored**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names ...Huge Alerts | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDividend cuts are destroying retirements… is yours next?The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWill the U.S. military protect this $10B gold mine?You don’t need the gold price to move another inch for this company to potentially re-rate several hundred per...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIT Stock Free XBIT Stock Alerts